Virus Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Dengue Fever Vaccines
Reports from University of Rome add new data to research in dengue fever vaccines
August 14th, 2007
Research findings, "Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach," are discussed in a new report. According to recent research published in the FEBS Journal, "Transmitted by the Aedes aegypti mosquito, the dengue virus is the etiological agent of dengue fever, dengue hemorrhagic fever and dengue shock syndrome, and, as such, is a significant factor in the high death rate found in most tropical and subtropical areas of the world. Dengue diseases are not only a health burden to developing countries, but pose an emerging problem worldwide." "The immunopathological mechanisms appear to include a...
Source: Virus Weekly (2007-08-14)
|
